M.C. Castiñeira

607 total citations · 1 hit paper
8 papers, 359 citations indexed

About

M.C. Castiñeira is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Nutrition and Dietetics. According to data from OpenAlex, M.C. Castiñeira has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Public Health, Environmental and Occupational Health and 2 papers in Nutrition and Dietetics. Recurrent topics in M.C. Castiñeira's work include Blood Pressure and Hypertension Studies (8 papers), Heart Rate Variability and Autonomic Control (5 papers) and Cardiovascular Health and Disease Prevention (3 papers). M.C. Castiñeira is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Heart Rate Variability and Autonomic Control (5 papers) and Cardiovascular Health and Disease Prevention (3 papers). M.C. Castiñeira collaborates with scholars based in Spain and United States. M.C. Castiñeira's co-authors include Elvira Sineiro, Manuel Domínguez-Sardiña, Pedro A. Callejas, Diana E. Ayala, José Luis Bernal Salgado, José R. Fernández, Carmen Durán, María T. Ríos, Alfonso Otero and Lorenzo Pousa and has published in prestigious journals such as European Heart Journal, Journal of Hypertension and Chronobiology International.

In The Last Decade

M.C. Castiñeira

7 papers receiving 350 citations

Hit Papers

Bedtime hypertension treatment improves cardiovascular ri... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

M.C. Castiñeira
M.C. Castiñeira
Citations per year, relative to M.C. Castiñeira M.C. Castiñeira (= 1×) peers Pedro A. Callejas

Countries citing papers authored by M.C. Castiñeira

Since Specialization
Citations

This map shows the geographic impact of M.C. Castiñeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Castiñeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Castiñeira more than expected).

Fields of papers citing papers by M.C. Castiñeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Castiñeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Castiñeira. The network helps show where M.C. Castiñeira may publish in the future.

Co-authorship network of co-authors of M.C. Castiñeira

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Castiñeira. A scholar is included among the top collaborators of M.C. Castiñeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Castiñeira. M.C. Castiñeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, et al.. (2020). Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure. Revista Española de Cardiología (English Edition). 74(11). 953–961. 5 indexed citations
2.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, et al.. (2020). La presión arterial ambulatoria, en comparación con la medida clínica, mejora notablemente la estratificación del riesgo cardiovascular de Framingham. Revista Española de Cardiología. 74(11). 953–961. 3 indexed citations
3.
Crespo, Juan J., Manuel Domínguez-Sardiña, Alfonso Otero, et al.. (2020). Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.. Chronobiology International. 37(5). 771–780. 2 indexed citations
4.
Crespo, Juan J., Manuel Domínguez-Sardiña, Alfonso Otero, et al.. (2020). The Hygia Project and Hygia Chronotherapy Trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health. Chronobiology International. 37(5). 759–766. 3 indexed citations
5.
Hermida, Ramón C., Juan J. Crespo, Manuel Domínguez-Sardiña, et al.. (2019). Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. European Heart Journal. 41(48). 4565–4576. 257 indexed citations breakdown →
6.
Hermida, Ramón C., Juan J. Crespo, Alfonso Otero, et al.. (2018). Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. European Heart Journal. 39(47). 4159–4171. 87 indexed citations
7.
Ayala, Diana E., Manuel Domínguez-Sardiña, A Otero, et al.. (2015). 1C.05. Journal of Hypertension. 33(Supplement 1). e10–e10. 2 indexed citations
8.
Domínguez-Sardiña, Manuel, M.C. Castiñeira, Antonio Ferreras, et al.. (2011). ALTERATION OF THE CIRCADIAN BLOOD PRESSURE PATTERN IN SUBJECTS WITH CHRONIC KIDNEY DISEASE: THE HYGIA PROJECT. Journal of Hypertension. 29. e174–e174.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026